These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8913648)
1. Anti-neutrophil cytoplasmic antibodies in patients with chromomycosis. Galperin C; Shoenfeld Y; Gilburd B; Esterre P; Meroni PL; Del Papa N; Halpern GM; Andriantsimahavandy A; Gershwin ME Clin Exp Rheumatol; 1996; 14(5):479-83. PubMed ID: 8913648 [TBL] [Abstract][Full Text] [Related]
2. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA). Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969 [TBL] [Abstract][Full Text] [Related]
3. A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies. Savige JA; Paspaliaris B; Silvestrini R; Davies D; Nikoloutsopoulos T; Sturgess A; Neil J; Pollock W; Dunster K; Hendle M J Clin Pathol; 1998 Aug; 51(8):568-75. PubMed ID: 9828813 [TBL] [Abstract][Full Text] [Related]
4. Analytical and diagnostic accuracy of the EliA automated enzyme fluoroimmunoassay for antineutrophil cytoplasmic autoantibody detection. Villalta D; Tonutti E; Tampoia M; Bizzaro N; Papisch W; Tozzoli R; Stella S Clin Chem Lab Med; 2004; 42(10):1161-7. PubMed ID: 15552276 [TBL] [Abstract][Full Text] [Related]
5. Contribution of immunofluorescence to the identification and characterization of anti-neutrophil cytoplasmic autoantibodies. The role of different fixatives. Radice A; Vecchi M; Bianchi MB; Sinico RA Clin Exp Rheumatol; 2000; 18(6):707-12. PubMed ID: 11138332 [TBL] [Abstract][Full Text] [Related]
6. Human mast cells expressing recombinant proteinase 3 (PR3) as substrate for clinical testing for anti-neutrophil cytoplasmic antibodies (ANCA). Specks U; Wiegert EM; Homburger HA Clin Exp Immunol; 1997 Aug; 109(2):286-95. PubMed ID: 9276524 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of classical and atypical antineutrophil cytoplasmic antibody (ANCA) immunofluorescence patterns. Wong RC; Silvestrini RA; Savige JA; Fulcher DA; Benson EM J Clin Pathol; 1999 Feb; 52(2):124-8. PubMed ID: 10396240 [TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of a capture ELISA for detection of proteinase-3 antineutrophil cytoplasmic antibody. Westman KW; Selga D; Bygren P; Segelmark M; Baslund B; Wiik A; Wieslander J Kidney Int; 1998 May; 53(5):1230-6. PubMed ID: 9573537 [TBL] [Abstract][Full Text] [Related]
9. A novel high sensitivity ELISA for detection of antineutrophil cytoplasm antibodies against proteinase-3. Hellmich B; Csernok E; Fredenhagen G; Gross WL Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S1-5. PubMed ID: 17428354 [TBL] [Abstract][Full Text] [Related]
10. Invasive amoebiasis is associated with the development of anti-neutrophil cytoplasmic antibody. Pudifin DJ; Duursma J; Gathiram V; Jackson TF Clin Exp Immunol; 1994 Jul; 97(1):48-51. PubMed ID: 8033420 [TBL] [Abstract][Full Text] [Related]
11. Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils. Van Rossum AP; van der Geld YM; Limburg PC; Kallenberg CG Kidney Int; 2005 Aug; 68(2):537-41. PubMed ID: 16014030 [TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis. Wong SN; Shah V; Dillon MJ Arch Dis Child; 1998 Sep; 79(3):246-50. PubMed ID: 9875021 [TBL] [Abstract][Full Text] [Related]
13. [Prevalence and specificity of antineutrophil cytoplasmic antibodies (ANCA) in connective tissue diseases]. Puszczewicz M; Zimmermann-Górska I; Białkowska-Puszczewicz G; Tuchocka A Pol Arch Med Wewn; 2003 Jan; 109(1):35-41. PubMed ID: 12879764 [TBL] [Abstract][Full Text] [Related]
14. Agreement of anti-neutrophil cytoplasmic antibody measurements obtained from serum and plasma. Lee AS; Finkielman JD; Peikert T; Hummel AM; Viss MA; Jacob GL; Homburger HA; Specks U; Clin Exp Immunol; 2006 Oct; 146(1):15-20. PubMed ID: 16968393 [TBL] [Abstract][Full Text] [Related]
15. Low seroprevalence and poor specificity of antineutrophil cytoplasmic antibodies in tuberculosis. Teixeira L; Mahr A; Jaureguy F; Noël LH; Nunes H; Lefort A; Barry S; Deny P; Guillevin L Rheumatology (Oxford); 2005 Feb; 44(2):247-50. PubMed ID: 15546964 [TBL] [Abstract][Full Text] [Related]
16. Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides. Van Der Geld YM; Simpelaar A; Van Der Zee R; Tervaert JW; Stegeman CA; Limburg PC; Kallenberg CG Kidney Int; 2001 Jan; 59(1):147-59. PubMed ID: 11135067 [TBL] [Abstract][Full Text] [Related]
17. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature. Reinhold-Keller E; de Groot K; Holl-Ulrich K; Arlt AC; Heller M; Feller AC; Gross WL Clin Exp Rheumatol; 2001; 19(5):541-9. PubMed ID: 11579713 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood. Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394 [TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA). Selak S; Woodman RC; Fritzler MJ Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260 [TBL] [Abstract][Full Text] [Related]
20. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients. Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]